Author/Authors :
Homaei Shandiz, Fatemeh Research Center of Solid Tumor Treatment - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Kadkhodayan, Sima Research Center of Women’s Health - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Hsanzade Mofrad, Malihe Research Center of Women’s Health - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Yousefi Roodsari, Zohre Research Center of Women’s Health - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Sharifi Sistani, Noorieh Research Center of Solid Tumor Treatment - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran , Nabizadeh Marvast, Majid Mashhad University of Medical Sciences, Mashhad, IR Iran , Sadeghei, Mahbobe Research Center of Solid Tumor Treatment - Ghaem Hospital - Mashhad University of Medical Sciences, Mashhad, IR Iran
Abstract :
Introduction: Malignant Mixed Mullerian Tumor (MMMT) is a very rare tumor, accounting for less than 1% of all ovarian cancers.
Case Presentation: We present a 64-year-old woman with stage III MMMT of ovary that was treated with platinum-based chemotherapy after optimal cytoreductive surgery. After 25 months of being disease free, she had a pelvic recurrence and a good response to chemoradiotherapy.
Conclusions: Optimal cytoreductive surgery and chemotherapy may be the best treatment in MMMT but more discussion and experiences are needed regarding the effectiveness of radiotherapy.
Keywords :
Mixed Tumor , Mullerian , Cytoreductive Surgery , Chemoradiotherapy , Chemotherapy , Ovary
